Offer - Urjas Oil for just ₹ 1 X
Rapilif 8 Mg Capsule (15) is a commercial drug that is prescribed in the form of Capsule. It is typically used for the treatment of Enlarged Prostate.
Medical history of the patient along with age and gender determines the dosage of Rapilif 8 Mg Capsule (15). The condition it has been prescribed for, and the route of administration also determine the right dosage. Refer to the dosage section for a detailed discussion.
While these are the most often observed Rapilif 8 Mg Capsule (15) side effects, there are can be others also. These have been listed below. Such side effects of Rapilif 8 Mg Capsule (15) normally do not last long and go away once the treatment is completed. Please speak with your doctor if these side effects worsen or persist for a longer duration.
Furthermore, you should know that effect of Rapilif 8 Mg Capsule (15) is Not Used By Women for pregnant women and Not Used By Women for women who are breastfeeding. It is important to know if Rapilif 8 Mg Capsule (15) has any effect on the kidney, liver and heart. Information on such adverse effects, if any, has been given in the Rapilif 8 Mg Capsule (15) related warnings section.
Rapilif 8 Mg Capsule (15) can cause adverse effects in certain medical conditions. It is strongly recommended to avoid Rapilif 8 Mg Capsule (15) in conditions like Kidney Disease, Liver Disease. Other conditions have been mentioned below in the Rapilif 8 Mg Capsule (15) contraindications section.
Drug interactions for Rapilif 8 Mg Capsule (15) have been reported in the medical literature. A complete list of these interactions is given below.
You should also be aware that Rapilif 8 Mg Capsule (15) is not safe while driving, and is not addiction.
Rapilif 8 Mg Capsule (15) is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
Is the use of Rapilif 8 Mg Capsule (15) safe for pregnant women?
Not Used by Women
Is the use of Rapilif 8 Mg Capsule (15) safe during breastfeeding?
Not Used by Women
What is the effect of Rapilif 8 Mg Capsule (15) on the Kidneys?
There can be some harmful effects on your kidneys after taking Rapilif. If you witness any side effects, discontinue its use. Consult your medical practitioner, do as he/she suggests.
What is the effect of Rapilif 8 Mg Capsule (15) on the Liver?
Rapilif may cause harmful effects on liver. if you feel it's having any such effect, then stop taking this drug, and restart only on your doctor's advice.
What is the effect of Rapilif 8 Mg Capsule (15) on the Heart?
Side effects of Rapilif rarely affect the heart.
If you are suffering from any of the following diseases, you should not take Rapilif 8 Mg Capsule (15) unless your doctor advises you to do so -
Is this Rapilif 8 Mg Capsule (15) habit forming or addictive?
No, there is no any evidence that Rapilif 8 Mg Capsule (15) is addictive.
Is it safe to drive or operate heavy machinery when consuming?
No, you should do not do anything that requires concentration and attention as the Rapilif 8 Mg Capsule (15) can make you feel drowsy.
Is it safe?
Rapilif 8 Mg Capsule (15) should be used only after doctor's advice.
Is it able to treat mental disorders?
No, Rapilif 8 Mg Capsule (15) is not used to treat mental disorders.
Interaction between Food and Rapilif 8 Mg Capsule (15)
There isn't any research available on the side effects of taking Rapilif 8 Mg Capsule (15) with food.
Interaction between Alcohol and Rapilif 8 Mg Capsule (15)
No research has been done on this till date. Therefore, it is not known what the effect of taking Rapilif 8 Mg Capsule (15) with alcohol will be.
This medicine data has been created by -
B.Pharma, Pharmacy
5 Years of Experience
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Rapaflo® (silodosin)
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 1137-1138